LifeWatch AG: Suit Brought Against LifeWatch Services, Inc. by Acacia Subsidiary Dismissed
March 02 2015 - 1:31AM
Business Wire
LifeWatch AG (SIX Swiss Exchange: LIFE), a leading provider of
medical solutions in remote cardiac monitoring, announces that a
patent case brought against the company by Body Science, LLC, a
subsidiary of Acacia Research Corp. ("Acacia"), has been dismissed
with prejudice by the District of Massachusetts court. LifeWatch
CEO, Dr. Stephan Rietiker, commented, "The Body Science, LLC case
ended as expected. We have in the past, and will continue in the
future, to vigorously defend the Company against patent trolls such
as Acacia and its subsidiaries."
About LifeWatch AG:
LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed
on SIX Swiss Exchange (LIFE), Switzerland, is a leading healthcare
technology and solution company,specializing in advanced telehealth
systems and wireless remote Patient monitoring services.
LifeWatch's services provide physicians with critical information
to determine appropriate treatment and thereby improve Patient
outcomes. LifeWatch AG has operative subsidiaries in the United
States, in Switzerland and in Israel, and is the parent company of
LifeWatch Services Inc., and LifeWatch Technologies, Ltd. LifeWatch
Services, Inc. is a leading U.S.-based provider of cardiac
monitoring services and home sleep testing of Obstructive Sleep
Apnea (OSA). LifeWatch Technologies Ltd., based in Israel, is a
leading developer and manufacturer of telemedicine products. For
additional information, please visit www.lifewatch.com.
Sign up for customized e-mail alerts and documentation requests
at http://www.irlifewatch.com/alert-service.aspx
This press release includes forward-looking statements. All
statements other than statements of historical facts contained in
this press release, including statements regarding future results
of operations and financial position, the business strategy, and
plans and objectives for future operations, are forward-looking
statements. The words 'believe,' 'may,' 'will,' 'estimate,'
'continue,' 'anticipate,' 'intend,' 'expect' and similar
expressions are intended to identify forward-looking statements.
LifeWatch AG has based these forward-looking statements largely on
current expectations and projections about future events and
financial trends that it believes may affect the financial
condition, results of operations, business strategy, short-term and
long-term business operations and objectives, and financial needs.
These forward-looking statements are subject to a number of risks,
uncertainties and assumptions. In light of these risks,
uncertainties and assumptions, the forward-looking events and
circumstances described may not occur and actual results could
differ materially and adversely from those anticipated or implied
in the forward-looking statements. All forward-looking statements
are based only on data available to LifeWatch AG at the time of the
issue of this press release. LifeWatch AG does not undertake any
obligation to update any forward-looking statements contained in
this press release as a result of new information, future events or
otherwise.
THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF
LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED
STATES, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY
SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED
STATES. IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS
SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES
SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN
THE UNITED STATES OR TO U.S. PERSONS ABSENT FROM REGISTRATION UNDER
OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF
THE UNITED STATES SECURITIES LAWS. ANY PUBLIC OFFERING OF
SECURITIES TO BE MADE IN THE UNITED STATES WILL BE MADE BY MEANS OF
A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG OR ITS
SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED INFORMATION
ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS
OF THE ISSUER.
Language: English Company: LifeWatch AG Rundbuckstrasse 6
8212 Neuhausen am Rheinfall Switzerland Phone: +41 52 632 00 50
Fax: +41 52 632 00 51 Internet:
www.lifewatch.com
ISIN: CH0012815459 Valor: 811189 Listed: Regulated Unofficial
Market in Berlin, Stuttgart; Open Market in Frankfurt ; SIX
LifeWatch AG c/o Dynamics GroupPhilippe Blangey / Doris
Rudischhauser, +41 43 268 32 35investor-relations@lifewatch.com
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From Mar 2024 to Apr 2024
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From Apr 2023 to Apr 2024